How to Choose? Polyclonal, Monoclonal, or Recombinant Antibody?With the rapid development of life science, researches on protein significantly mount, highlighting the prominent roles of antibodies in experiments. Facing the diverse and complex antibody reagent market, it is particul...
Detailed information

Does LIF Only Play a Role in Leukaemia?Leukemia inhibitory factor (LIF) is a cytokine which belongs to the IL-6 superfamily. LIF derives its name from its ability to inhibit proliferation of myeloid leukemia cells in culture [1]. As the research of LIF progre...
Detailed information

DLL3: A New Molecular Target in CancerOn October 24, 2024, Zai Lab, a biopharmaceutical company based in the U.S. and China, announced at the EORTC-NCI-AACR (ENA) meeting that its ZL-1310, an antibody-drug conjugate (ADC) targeting DLL3, demonstrated signifi...
Detailed information

What Is Tomato Mosaic VirusTomato mosaic virus (ToMV), first reported in the United States in 1909, is a type of plant virus with worldwide distribution and can cause severe damage to various crops [1]. So exactly what is the tomato mosaic virus? ...
Detailed information

Does Antibody-dependent Enhancement Occur in SARS-CoV-2 Infection?In 1964, Hawkes et al. demonstrated enhanced infectivity of viruses, including arboviruses, Murray Valley encephalitis virus, West Nile virus (WNV), Japanese encephalitis virus (JEV), and Getah viruses in the presence of...
Detailed information

The Overview of Cell ViabilityCell-based assays are generic tools for measuring numerous biochemical or cellular functions. Bioassays can study various events including cell proliferation, morphology, migration, apoptosis, genetics, and signal tran...
Detailed information

What Are Histones: Unraveling Their Critical Roles in Disease PathogenesisHistones are fundamental proteins that play a vital role in the packaging, organization, and regulation of DNA within the nucleus of eukaryotic cells. They form the building blocks of chromatin, the complex structure in ...
Detailed information

Claudin 18.2, is a 'Dark Horse' in Anti-tumour Therapy?In May, 2020, the world's first CAR-T therapy targeting Claudin 18.2 was approved in the US; in June, 2020, the world's first Claudin 18.2/PD-L1 bispecific antibody preclinical data was presented at the AACR; and on July...
Detailed information

GPC3: The Next-Promising Target in Cancer ImmunotherapyIn recent years, glypican-3 (GPC3) has emerged as a highly promising specific target for hepatocellular carcinoma (HCC) and other solid tumors, with its translational research advancing at an unprecedented pace. From 202...
Detailed information

Neuronal Markers and Neurodegenerative DiseasesNeurons are highly specialized nerve cells that receive and transmit electrical or chemical signals to coordinate all of the necessary functions for life. Neurons are typically composed of a cell body, dendrites, an ax...
Detailed information